Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Mitigation of indomethacin-induced gastric mucosal lesions by a potent specific type V phosphodiesterase inhibitor
World Journal of Gastroenterology, 11/02/09
Karakaya K et al. – Vardenafil affords a significant dose–dependent protection against indomethacin induced gastric mucosal lesions.
Related Articles
"Glassy" Cells in Barrett's Mucosa
Anticancer Research, 11/11/09
Relevance Score: 68%
Reactive Nitrogen Species Mediate DNA Damage in Helicobacter pylori-Infected Gastric Mucosa
Helicobacter, 11/09/09
Relevance Score: 67%
Persistence of a component of DNA methylation in gastric mucosae after Helicobacter pylori eradication
Journal of Gastroenterology, 10/13/09
Relevance Score: 66%
Inhibitory effect of IL-4 on the production of IL-1[beta] and TNF-[alpha] by gastric mononuclear cells of Helicobacter pylori infected patients
Irish Journal of Medical Science, 11/09/09
Relevance Score: 65%
An evidence-based consensus statement on the role and application of endosonography in clinical practice
Endoscopy, 10/30/09
Relevance Score: 65%
Today in Gastroenterology...keeping you current
Receive free subspecialty "5-minute updates" via email
Thiazolidinediones and the liver in humans
Current Opinion in Lipidology, 12/14/09
Severe hypertriglyceridemia and pancreatitis: presentation and management
Current Opinion in Lipidology, 12/14/09
Role of Placental Growth Factor in Mesenteric Neoangiogenesis in a Model of Portal Hypertension
Gastroenterology, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


